> top > docs > PMC:2674207 > spans > 34386-34744 > annotations

PMC:2674207 / 34386-34744 JSONTXT

Annnotations TAB JSON ListView MergeView

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T11327 0-9 NN denotes Treatment
T11328 10-14 IN denotes with
T11329 15-17 NN denotes FP
T11330 18-20 FW denotes ex
T11331 21-25 FW denotes vivo
T11332 26-38 VB denotes demonstrated
T11333 39-40 DT denotes a
T11334 41-64 JJ denotes concentration-dependent
T11335 65-73 NN denotes decrease
T11336 74-76 IN denotes in
T11337 77-80 DT denotes the
T11338 81-87 JJ denotes direct
T11339 88-99 NN denotes interaction
T11340 100-107 IN denotes between
T11341 108-122 NN denotes phospho-GATA-3
T11342 123-126 CC denotes and
T11343 127-137 NN denotes importin-α
T11344 138-140 IN denotes in
T11345 141-146 NN denotes PBMCs
T11346 147-151 IN denotes from
T11347 152-160 NN denotes patients
T11348 161-165 IN denotes with
T11349 166-172 NN denotes asthma
T11350 173-174 -LRB- denotes (
T11351 174-180 NN denotes Figure
T11352 181-183 NN denotes 6A
T11353 184-187 CC denotes and
T11354 188-190 NN denotes 6B
T11355 190-191 -RRB- denotes )
T11356 191-192 -COMMA- denotes ,
T11357 193-198 WDT denotes which
T11358 199-202 VB denotes was
T11359 203-216 RB denotes significantly
T11360 217-226 VB denotes inhibited
T11361 227-229 IN denotes at
T11362 230-235 CD denotes 10−12
T11363 236-237 NN denotes M
T11364 238-240 NN denotes FP
T11365 241-242 -LRB- denotes (
T11366 242-243 NN denotes p
T11367 243-244 JJ denotes <
T11368 244-249 CD denotes 0.001
T11369 249-250 -COMMA- denotes ,
T11370 251-256 NN denotes ANOVA
T11371 257-260 CC denotes and
T11372 261-273 NNP denotes Newman-Keuls
T11373 274-278 NN denotes test
T11374 278-279 -RRB- denotes )
T11375 280-283 CC denotes and
T11376 284-294 RB denotes completely
T11377 295-305 VB denotes attenuated
T11378 306-308 IN denotes by
T11379 309-313 CD denotes 10−8
T11380 314-315 NN denotes M
T11381 316-318 NN denotes FP
T11382 319-320 -LRB- denotes (
T11383 320-321 NN denotes p
T11384 321-322 JJ denotes <
T11385 322-327 CD denotes 0.001
T11386 327-328 -COMMA- denotes ,
T11387 329-334 NN denotes ANOVA
T11388 335-338 CC denotes and
T11389 339-351 NNP denotes Newman-Keuls
T11390 352-356 NN denotes test
T11391 356-357 -RRB- denotes )
R9662 T11327 T11328 arg1Of Treatment,with
R9663 T11327 T11332 arg1Of Treatment,demonstrated
R9664 T11329 T11328 arg2Of FP,with
R9665 T11329 T11331 arg1Of FP,vivo
R9666 T11331 T11330 arg1Of vivo,ex
R9667 T11335 T11332 arg2Of decrease,demonstrated
R9668 T11335 T11333 arg1Of decrease,a
R9669 T11335 T11334 arg1Of decrease,concentration-dependent
R9670 T11335 T11336 arg1Of decrease,in
R9671 T11339 T11336 arg2Of interaction,in
R9672 T11339 T11337 arg1Of interaction,the
R9673 T11339 T11338 arg1Of interaction,direct
R9674 T11339 T11340 arg1Of interaction,between
R9675 T11341 T11342 arg1Of phospho-GATA-3,and
R9676 T11342 T11340 arg2Of and,between
R9677 T11342 T11344 arg1Of and,in
R9678 T11342 T11356 arg1Of and,","
R9679 T11342 T11357 arg1Of and,which
R9680 T11342 T11358 arg1Of and,was
R9681 T11342 T11360 arg2Of and,inhibited
R9682 T11342 T11377 arg2Of and,attenuated
R9683 T11343 T11342 arg2Of importin-α,and
R9684 T11345 T11344 arg2Of PBMCs,in
R9685 T11345 T11346 arg1Of PBMCs,from
R9686 T11347 T11346 arg2Of patients,from
R9687 T11347 T11348 arg1Of patients,with
R9688 T11347 T11350 arg1Of patients,(
R9689 T11349 T11348 arg2Of asthma,with
R9690 T11352 T11351 arg1Of 6A,Figure
R9691 T11352 T11353 arg1Of 6A,and
R9692 T11353 T11350 arg2Of and,(
R9693 T11354 T11353 arg2Of 6B,and
R9694 T11355 T11350 arg3Of ),(
R9695 T11360 T11361 arg1Of inhibited,at
R9696 T11360 T11375 arg1Of inhibited,and
R9697 T11362 T11363 arg1Of 10−12,M
R9698 T11364 T11361 arg2Of FP,at
R9699 T11364 T11362 arg1Of FP,10−12
R9700 T11364 T11365 arg1Of FP,(
R9701 T11366 T11365 arg2Of p,(
R9702 T11366 T11367 arg1Of p,<
R9703 T11366 T11369 arg1Of p,","
R9704 T11367 T11368 arg1Of <,0.001
R9705 T11370 T11371 arg1Of ANOVA,and
R9706 T11371 T11369 arg2Of and,","
R9707 T11373 T11371 arg2Of test,and
R9708 T11373 T11372 arg1Of test,Newman-Keuls
R9709 T11374 T11365 arg3Of ),(
R9710 T11375 T11358 arg2Of and,was
R9711 T11375 T11359 arg1Of and,significantly
R9712 T11377 T11375 arg2Of attenuated,and
R9713 T11377 T11376 arg1Of attenuated,completely
R9714 T11379 T11380 arg1Of 10−8,M
R9715 T11381 T11377 arg1Of FP,attenuated
R9716 T11381 T11378 arg2Of FP,by
R9717 T11381 T11379 arg1Of FP,10−8
R9718 T11381 T11382 arg1Of FP,(
R9719 T11383 T11382 arg2Of p,(
R9720 T11383 T11384 arg1Of p,<
R9721 T11383 T11386 arg1Of p,","
R9722 T11384 T11385 arg1Of <,0.001
R9723 T11387 T11388 arg1Of ANOVA,and
R9724 T11388 T11386 arg2Of and,","
R9725 T11390 T11388 arg2Of test,and
R9726 T11390 T11389 arg1Of test,Newman-Keuls
R9727 T11391 T11382 arg3Of ),(

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T11940 0-9 NNP denotes Treatment
T11941 10-14 IN denotes with
T11942 15-17 NNP denotes FP
T11943 18-20 FW denotes ex
T11944 21-25 FW denotes vivo
T11945 26-38 VBD denotes demonstrated
T11946 39-40 DT denotes a
T11947 41-64 JJ denotes concentration-dependent
T11948 65-73 NN denotes decrease
T11949 74-76 IN denotes in
T11950 77-80 DT denotes the
T11951 81-87 JJ denotes direct
T11952 88-99 NN denotes interaction
T11953 100-107 IN denotes between
T11954 108-122 JJ denotes phospho-GATA-3
T11955 123-126 CC denotes and
T11956 127-137 JJ denotes importin-α
T11957 138-140 IN denotes in
T11958 141-146 NNS denotes PBMCs
T11959 147-151 IN denotes from
T11960 152-160 NNS denotes patients
T11961 161-165 IN denotes with
T11962 166-172 NN denotes asthma
T11963 173-174 -LRB- denotes (
T11964 174-180 NN denotes Figure
T11965 181-183 NN denotes 6A
T11966 184-187 CC denotes and
T11967 188-190 NN denotes 6B
T11968 190-191 -RRB- denotes )
T11969 191-192 , denotes ,
T11970 193-198 WDT denotes which
T11971 199-202 VBD denotes was
T11972 203-216 RB denotes significantly
T11973 217-226 VBN denotes inhibited
T11974 227-229 IN denotes at
T11975 230-232 CD denotes 10
T11976 232-233 CD denotes −
T11977 233-235 CD denotes 12
T11978 236-237 NNP denotes M
T11979 238-240 NNP denotes FP
T11980 241-242 -LRB- denotes (
T11981 242-243 FW denotes p
T11982 243-244 FW denotes <
T11983 244-249 CD denotes 0.001
T11984 249-250 , denotes ,
T11985 251-256 NNP denotes ANOVA
T11986 257-260 CC denotes and
T11987 261-273 NNP denotes Newman-Keuls
T11988 274-278 NN denotes test
T11989 278-279 -RRB- denotes )
T11990 280-283 CC denotes and
T11991 284-294 RB denotes completely
T11992 295-305 VBN denotes attenuated
T11993 306-308 IN denotes by
T11994 309-311 CD denotes 10
T11995 311-312 NN denotes −
T11996 312-313 CD denotes 8
T11997 314-315 NNP denotes M
T11998 316-318 NNP denotes FP
T11999 319-320 -LRB- denotes (
T12000 320-321 FW denotes p
T12001 321-322 FW denotes <
T12002 322-327 CD denotes 0.001
T12003 327-328 , denotes ,
T12004 329-334 NNP denotes ANOVA
T12005 335-338 CC denotes and
T12006 339-351 NNP denotes Newman-Keuls
T12007 352-356 NN denotes test
T12008 356-357 -RRB- denotes )
T12009 357-358 . denotes .
R10256 T11943 T11944 nmod ex,vivo
R10257 T11944 T11945 nsubj vivo,demonstrated
R10258 T11945 T11945 ROOT demonstrated,demonstrated
R10259 T11946 T11948 det a,decrease
R10260 T11947 T11948 amod concentration-dependent,decrease
R10261 T11948 T11945 dobj decrease,demonstrated
R10262 T11949 T11948 prep in,decrease
R10263 T11950 T11952 det the,interaction
R10264 T11951 T11952 amod direct,interaction
R10265 T11952 T11949 pobj interaction,in
R10266 T11953 T11952 prep between,interaction
R10267 T11954 T11953 pobj phospho-GATA-3,between
R10268 T11955 T11954 cc and,phospho-GATA-3
R10269 T11956 T11954 conj importin-α,phospho-GATA-3
R10270 T11957 T11956 prep in,importin-α
R10271 T11958 T11957 pobj PBMCs,in
R10272 T11959 T11954 prep from,phospho-GATA-3
R10273 T11960 T11959 pobj patients,from
R10274 T11961 T11960 prep with,patients
R10275 T11962 T11965 compound asthma,6A
R10276 T11963 T11964 punct (,Figure
R10277 T11964 T11965 compound Figure,6A
R10278 T11965 T11961 pobj 6A,with
R10279 T11966 T11965 cc and,6A
R10280 T11967 T11965 conj 6B,6A
R10281 T11968 T11967 punct ),6B
R10282 T11969 T11965 punct ",",6A
R10283 T11970 T11973 nsubjpass which,inhibited
R10284 T11971 T11973 auxpass was,inhibited
R10285 T11972 T11973 advmod significantly,inhibited
R10286 T11973 T11960 relcl inhibited,patients
R10287 T11974 T11973 prep at,inhibited
R10288 T11975 T11979 nummod 10,FP
R10289 T11976 T11979 nummod −,FP
R10290 T11977 T11979 nummod 12,FP
R10291 T11978 T11979 compound M,FP
R10292 T11979 T11974 pobj FP,at
R10293 T11980 T11979 punct (,FP
R10294 T11981 T11982 nmod p,<
R10295 T11982 T11983 nmod <,0.001
R10296 T11983 T11979 appos 0.001,FP
R10297 T11984 T11983 punct ",",0.001
R10298 T11985 T11983 conj ANOVA,0.001
R10299 T11986 T11985 cc and,ANOVA
R10300 T11987 T11988 compound Newman-Keuls,test
R10301 T11988 T11985 conj test,ANOVA
R10302 T11989 T11988 punct ),test
R10303 T11990 T11973 cc and,inhibited
R10304 T11991 T11992 advmod completely,attenuated
R10305 T11992 T11973 conj attenuated,inhibited
R10306 T11993 T11992 prep by,attenuated
R10307 T11994 T11998 nummod 10,FP
R10308 T11995 T11996 quantmod −,8
R10309 T11996 T11998 nummod 8,FP
R10310 T11997 T11998 compound M,FP
R10311 T11998 T12001 nmod FP,<
R10312 T11999 T12001 punct (,<
R10313 T12000 T12001 nmod p,<
R10314 T12001 T11993 pobj <,by
R10315 T12002 T12001 appos 0.001,<
R10316 T12003 T12001 punct ",",<
R10317 T12004 T12001 conj ANOVA,<
R10318 T12005 T12004 cc and,ANOVA
R10319 T12006 T12007 compound Newman-Keuls,test
R10320 T12007 T12004 conj test,ANOVA
R10321 T12008 T12001 punct ),<
R10322 T12009 T11945 punct .,demonstrated
R10254 T11941 T11940 prep with,Treatment
R10255 T11942 T11944 compound FP,vivo

sentences

Id Subject Object Predicate Lexical cue
T11292 0-358 Sentence denotes Treatment with FP ex vivo demonstrated a concentration-dependent decrease in the direct interaction between phospho-GATA-3 and importin-α in PBMCs from patients with asthma (Figure 6A and 6B), which was significantly inhibited at 10−12 M FP (p<0.001, ANOVA and Newman-Keuls test) and completely attenuated by 10−8 M FP (p<0.001, ANOVA and Newman-Keuls test).
T233 0-358 Sentence denotes Treatment with FP ex vivo demonstrated a concentration-dependent decrease in the direct interaction between phospho-GATA-3 and importin-α in PBMCs from patients with asthma (Figure 6A and 6B), which was significantly inhibited at 10−12 M FP (p<0.001, ANOVA and Newman-Keuls test) and completely attenuated by 10−8 M FP (p<0.001, ANOVA and Newman-Keuls test).

ICD10

Id Subject Object Predicate Lexical cue
T12585 166-172 http://purl.bioontology.org/ontology/ICD10/J45.9 denotes asthma
T12587 166-172 http://purl.bioontology.org/ontology/ICD10/J45 denotes asthma

events-check-again

Id Subject Object Predicate Lexical cue
T12735 55-64 Regulation denotes dependent
T12736 65-73 Negative_regulation denotes decrease
T12737 88-99 Binding denotes interaction
T12738 108-115 Phosphorylation denotes phospho
T12739 116-122 Protein denotes GATA-3
T12740 217-226 Negative_regulation denotes inhibited
T12741 295-305 Negative_regulation denotes attenuated
R10970 T12736 T12735 themeOf decrease,dependent
R10971 T12737 T12736 themeOf interaction,decrease
R10972 T12737 T12740 themeOf interaction,inhibited
R10973 T12737 T12741 themeOf interaction,attenuated
R10974 T12739 T12737 themeOf GATA-3,interaction
R10975 T12739 T12738 themeOf GATA-3,phospho

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T12798 108-122 Protein denotes phospho-GATA-3
T12799 127-137 Protein denotes importin-α
T12800 88-99 Binding denotes interaction
T12801 65-73 Negative_regulation denotes decrease
R11016 T12798 T12800 themeOf phospho-GATA-3,interaction
R11017 T12799 T12800 themeOf importin-α,interaction
R11018 T12800 T12801 themeOf interaction,decrease

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue
T11228 55-64 Regulation denotes dependent
T11229 65-73 Negative_regulation denotes decrease
T11230 88-99 Binding denotes interaction
T11231 108-115 Phosphorylation denotes phospho
T11232 116-122 Protein denotes GATA-3
T11233 217-226 Negative_regulation denotes inhibited
T11234 295-305 Negative_regulation denotes attenuated
R9599 T11229 T11228 themeOf decrease,dependent
R9600 T11230 T11229 themeOf interaction,decrease
R9601 T11230 T11233 themeOf interaction,inhibited
R9602 T11230 T11234 themeOf interaction,attenuated
R9603 T11232 T11230 themeOf GATA-3,interaction
R9604 T11232 T11231 themeOf GATA-3,phospho

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T11897 116-122 P23771 denotes GATA-3

test2

Id Subject Object Predicate Lexical cue
T11164 55-64 Regulation denotes dependent
T11165 65-73 Negative_regulation denotes decrease
T11166 88-99 Binding denotes interaction
T11167 108-115 Phosphorylation denotes phospho
T11168 116-122 Protein denotes GATA-3
T11169 217-226 Negative_regulation denotes inhibited
T11170 295-305 Negative_regulation denotes attenuated
R9551 T11166 T11165 themeOf interaction,decrease
R9552 T11166 T11170 themeOf interaction,attenuated
R9553 T11166 T11169 themeOf interaction,inhibited
R9554 T11167 T11170 themeOf phospho,attenuated
R9555 T11167 T11169 themeOf phospho,inhibited
R9556 T11168 T11166 themeOf GATA-3,interaction
R9557 T11168 T11167 themeOf GATA-3,phospho